Skip to main content

De-Escalation of Locoregional Therapy in Low-Risk Disease for DCIS and Early-Stage Invasive Cancer.

Publication ,  Journal Article
Hwang, ES; Solin, L
Published in: J Clin Oncol
July 10, 2020

Duke Scholars

Published In

J Clin Oncol

DOI

EISSN

1527-7755

Publication Date

July 10, 2020

Volume

38

Issue

20

Start / End Page

2230 / 2239

Location

United States

Related Subject Headings

  • Retrospective Studies
  • Randomized Controlled Trials as Topic
  • Oncology & Carcinogenesis
  • Neoplasm Staging
  • Humans
  • Female
  • Carcinoma, Intraductal, Noninfiltrating
  • Carcinoma, Ductal, Breast
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Hwang, E. S., & Solin, L. (2020). De-Escalation of Locoregional Therapy in Low-Risk Disease for DCIS and Early-Stage Invasive Cancer. J Clin Oncol, 38(20), 2230–2239. https://doi.org/10.1200/JCO.19.02888
Hwang, E Shelley, and Lawrence Solin. “De-Escalation of Locoregional Therapy in Low-Risk Disease for DCIS and Early-Stage Invasive Cancer.J Clin Oncol 38, no. 20 (July 10, 2020): 2230–39. https://doi.org/10.1200/JCO.19.02888.
Hwang, E. Shelley, and Lawrence Solin. “De-Escalation of Locoregional Therapy in Low-Risk Disease for DCIS and Early-Stage Invasive Cancer.J Clin Oncol, vol. 38, no. 20, July 2020, pp. 2230–39. Pubmed, doi:10.1200/JCO.19.02888.

Published In

J Clin Oncol

DOI

EISSN

1527-7755

Publication Date

July 10, 2020

Volume

38

Issue

20

Start / End Page

2230 / 2239

Location

United States

Related Subject Headings

  • Retrospective Studies
  • Randomized Controlled Trials as Topic
  • Oncology & Carcinogenesis
  • Neoplasm Staging
  • Humans
  • Female
  • Carcinoma, Intraductal, Noninfiltrating
  • Carcinoma, Ductal, Breast
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis